Bellevue Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-57,600
| Closed | -$266K | – | 167 |
|
|
2024
Q2 | $266K | Hold |
57,600
| – | – | ﹤0.01% | 142 |
|
|
2024
Q1 | $471K | Sell |
57,600
-4,400
| -7% | -$35.9K | 0.01% | 132 |
|
|
2023
Q4 | $350K | Buy |
+62,000
| New | +$350K | 0.01% | 144 |
|
|
2022
Q2 | – | Sell |
-54,500
| Closed | -$1.32M | – | 176 |
|
|
2022
Q1 | $1.32M | Buy |
54,500
+7,300
| +15% | +$177K | 0.02% | 141 |
|
|
2021
Q4 | $1.52M | Hold |
47,200
| – | – | 0.02% | 151 |
|
|
2021
Q3 | $2.11M | Buy |
47,200
+16,200
| +52% | +$724K | 0.02% | 146 |
|
|
2021
Q2 | $1.17M | Buy |
+31,000
| New | +$1.17M | 0.01% | 150 |
|